Whole Foods weight loss shakes 'perfect for busy mums' that 'tastes like a holiday'
Protein shakes can help people stay fuller for longer, keeping cravings at bay
For those trying to lose weight and live a healthier lifestyle, the influx of information about supplements, protein shakes, meals-in-a-bottle and more can be overwhelming. When it comes to protein, however, it's important to remember that it is one of the major components of a healthy, functional body and can help people stay fuller for longer - which will naturally help with weight loss - along with other health benefits such as both health and digestion.
That said, it can be difficult for people to hit their protein goals. Busy lives mean may find themselves snacking on foods like chocolate and crisps which, while convenient when on the go, aren't actually going to keep them satisfied and can cause issues such as feeling bloated or sluggish.
However, there are plenty of products on the market that make hitting protein goals easier, even when people don't have access to a kitchen to whip up some chicken and rice: Daily Shake, for example, offers loads of flavours of protein shakes and is now available after selling out at Whole Foods UK and Supercare Pharmacies in Dubai.
The Daily Shake is described as Australia's tastiest health shake after going viral online. Often, protein shakes aren't the nicest drink to chug down, but these shakes are available in a number of flavours including chocolate souffle, whipped coffee, mango, strawberry cheesecake and even baklava - meaning shoppers can actually enjoy themselves while hitting their fitness and wellbeing goals.
The jar of protein mix, which is now available for £36, offers up to 10 servings and has a high 23-26 grams of faba and pea protein in each 203-calorie shake. It also has a blend of 27 vitamins and minerals to support overall health and is designed to enhance energy levels, boost immunity and promote healthy skin, hair and nails with zinc and vitamin C elements.
Alternatively, Daily Shake offers the Weight Loss Starter Pack, which includes 20 Sachets (two each of the 10 flavours), as well as a 400ml shaker and an electric mixer. Originally costing £106, it's now down to £83.
The Daily Shake is also said to help with bloating, as it has added biotin which supports natural collagen production - a digestive enzyme blend to help de-bloat. It has zero added sugar, is an all-natural, non-GMO shake and completely vegan and dairy free. To prepare the shake, simply add two scoops of the powder to 300ml of water and shake well.
If shoppers aren't feeling totally aligned with this shake, they could try a cheaper option with the Slimfast Cafe Latte Powder for £8 from Superdrug. This shake comes in a 584 gram box, features 23 vitamins and minerals, is high in protein and a great source of fibre. It can also give up to 16 servings to buyers.
Another option could be the Protein Meal Replacement Blend for £8.99 from MyProtein for anyone who wants to replace meals with a 200 calorie shake that contains 17g of high-quality protein. The flavours come in vanilla, banana, chocolate, salted caramel and strawberry in a 500 gram bag.
However, the Daily Shake went viral for a reason, and shoppers have shared their thoughts on the brands website. One shopper said: 'Loving all the options as a busy mum!'
Another wrote: 'I love this flavour. It tastes like vacation and keeps me full all morning! I will definitely be ordering more.'
'My Daily Shake gets me up in the morning and ready to go. I love the taste and that the ingredients - especially the MCT - gives me the energy I need to sustain myself during everyday exercise as well as my weekly paddle tournaments! The sachets make it super easy for me to take to the pool for after laps or to the Padel courts and gym!' said another buyer.
Not everyone was a fan of the Daily Shake, however, and some shared opposing views. One customer said: 'The protein shake flavour is a bit powdery despite shaking it for over one minute and the shake becoming smooth, but I can still make out a bit of the intended flavours.'
Another said: 'The subtlety works for some of these but I would have preferred a stronger flavour profile on some!'
For a product that has gone viral and is now back in stock across UK shops and online however, the Daily Shake could be a tasty and healthy option to try.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
7 hours ago
- The Independent
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Common GLP-1 weight loss drugs - including Wegovy and Ozempic - may not work for everyone in a 'real-world' setting, Cleveland Clinic researchers said Tuesday. The reason is that patients may take lower dosages or discontinue their treatment, negatively impacting the ability to control blood sugar levels in those who are pre-diabetic. The findings may have implications for people considering using the drugs, that are taken by more than eight million Americans every year. They've offered an alternative to traditional and taxing weight loss methods, such as diets and fitness. 'Our study shows that patients treated for obesity with semaglutide or trizepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trials,' Dr. Hamlet Gasoyan, a researcher with Cleveland Clinic, said in a statement. 'According to our data, this could be explained by higher rates of discontinuation and lower maintenance dosages used in clinical practice, compared to randomized clinical trial settings.' Gasoyan was the lead author of the study published on Tuesday in the Obesity Journal. A request for comment from the drugmakers Novo Nordisk and Eli Lilly was not immediately returned to The Independent. The study focuses on drugs with the active ingredients semaglutide and tirzepatide; they include the U.S. Food and Drug-administration approved type 2 diabetes medications Zepbound and Mounjaro. The authors studied their effects on weight loss and blood sugar regulation in a real-world setting. They noted that previous randomized clinical trials have shown the efficacy of those medications. The authors monitored the health of nearly 7,900 adults who were severely obese. Of those, more than 1,300 had pre-diabetes at the study's start and were at a higher risk for developing type 2 diabetes: a chronic condition that affects a person's ability to use insulin and keep blood sugar at normal levels. Participants took the shots between 2021 and 2023. The researchers sorted patients who discontinued their obesity medications into two groups: those who did it within just three months and by three months to a year. The study's follow-up period ended last December. The most common reasoning for discontinuation of treatment in the real-world setting was due to the steep cost of the drugs and insurance, side effects and shortages. Notably, since the study's, prices have started to fall. Of the participants, more than 20 percent discontinued their medications early and 32 percent discontinued their medications late. Furthermore, the authors noted than more than 80 percent had been on the lower dosages needed to sustain a therapeutic effect. For semaglutide, that's equal to or less than 1 milligram and equal to or less than 7.5 milligrams for tirzepatide. Following a year of treatment, the average weight reduction was 3.6 percent among participants who discontinued their treatment early, compared to 6.8 percent for those who discontinued their treatment late. But, those who did not discontinue treatment and were on the highest dosages necessary lost the most weight, at up to 13.7 percent with semaglutide and 18 percent with tirzepatide. Participants had higher odds of achieving 10 percent or greater weight reduction after one year of treatment if they did not discontinue their medications or did so late, were on the highest dosages needed for a therapeutic effect, received tirzepatide, and were women. Tracking the maintenance of blood sugar levels in those with pre-diabetes, the researchers said just a third of those who discontinued their treatment early experienced normal blood sugar levels compared to 41 percent who discontinued their treatment late and 67.9 percent who did not discontinue treatment. Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight compared to those who did not, their weight trajectories remained relatively stable. They said that would be the subject of additional research. 'Our findings about the real-world use patterns of these medications and associated clinical outcomes could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions,' explained Gasoyan.
Evening Standard
9 hours ago
- Evening Standard
Daily Shake meal replacement drinks take the headache out of meal planning
What's more, Daily Shake takes care of much more internally than you'd initially think. The blend includes pre- and probiotics to boost gut health, plus biotin and zinc for healthy hair and nails, and vitamin C to support natural collagen production, so it acts as far more than a weight loss aid. Indeed, the company says, 'Daily Shake can be used for busy people making sure they are taking care of themselves, people trying to lose weight or manage weight and even weight gain.'
Reuters
10 hours ago
- Reuters
Novo Nordisk starts new CagriSema weightloss drug trial
COPENHAGEN, June 10 (Reuters) - Novo Nordisk ( opens new tab has launched a new late-stage trial for its experimental next-generation obesity drug candidate, CagriSema, as it tries to reassure the market of its potential after disappointing data from two previous studies. The Danish company made the announcement in an entry published on opens new tab "This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term," Novo Nordisk said in the entry.
